{"Symbol": "ADPT", "AssetType": "Common Stock", "Name": "Adaptive Biotechnologies Corp", "Description": "Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company is headquartered in Seattle, Washington.", "CIK": "1478320", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "1165 EASTLAKE AVENUE EAST, SEATTLE, WA, UNITED STATES, 98109", "OfficialSite": "https://www.adaptivebiotech.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-12-31", "MarketCapitalization": "2466622000", "EBITDA": "-38939004", "PERatio": "None", "PEGRatio": "0", "BookValue": "1.423", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-0.39", "RevenuePerShareTTM": "1.826", "ProfitMargin": "-0.215", "OperatingMarginTTM": "-0.178", "ReturnOnAssetsTTM": "-0.0679", "ReturnOnEquityTTM": "-0.278", "RevenueTTM": "276976000", "GrossProfitTTM": "111848000", "DilutedEPSTTM": "-0.39", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0.51", "AnalystTargetPrice": "20.86", "AnalystRatingStrongBuy": "2", "AnalystRatingBuy": "5", "AnalystRatingHold": "1", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "8.91", "PriceToBookRatio": "11.27", "EVToRevenue": "8.37", "EVToEBITDA": "-0.999", "Beta": "2.181", "52WeekHigh": "20.76", "52WeekLow": "6.25", "50DayMovingAverage": "16.84", "200DayMovingAverage": "13.77", "SharesOutstanding": "153779000", "SharesFloat": "119365000", "PercentInsiders": "2.051", "PercentInstitutions": "99.745", "DividendDate": "None", "ExDividendDate": "None"}